Opus Genetics (IRD) Tax Provisions (2022 - 2025)

Opus Genetics' (IRD) quarterly Tax Provisions came in at -$10.4 million in Q4 2025, down 520600.0% on a QoQ basis from -$2000.0 in Q4 2023.

Opus Genetics (IRD) Tax Provisions (2022 - 2025) Analysis & Trends

Opus Genetics (IRD) has 3 years of Tax Provisions data on file, last reported at -$10.4 million in Q4 2025.

  • On a quarterly basis, Tax Provisions changed N/A year-over-year to -$10.4 million in Q4 2025; TTM through Mar 2026 was -$10.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$10.4 million, changed N/A from the prior year.
  • Tax Provisions for Q4 2025 stood at -$10.4 million, down from -$2000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for IRD reached as high as $315000.0 in Q4 2022 and fell as low as -$10.4 million in Q4 2025.
  • Historically, Tax Provisions has averaged -$2.5 million across 3 years, with a median of $6000.0 in 2023.
  • On a YoY basis, Tax Provisions climbed as much as 100.63% in 2023 and fell as far as 100.63% in 2023.
  • Year by year, Tax Provisions stood at $315000.0 in 2022, then slumped by 100.63% to -$2000.0 in 2023, then tumbled by 520600.0% to -$10.4 million in 2025.
  • Per Business Quant data, the three most recent Tax Provisions figures were -$10.4 million in Q4 2025, -$2000.0 in Q4 2023, and $14000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 125,146.46
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 31.86 Mn
4 NuCana 279.75 Bn 279.75 Bn - 188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 179.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Opus Genetics 3.27 Mn -56.73 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -10.41 Mn
Dec 31, 2023 -2,000.00
Sep 30, 2023 14,000.00
Dec 31, 2022 315,000.00